10-Q: Medicale Corp. Reports Q2 2025 Results: Net Loss Narrows Amid Ongoing Efforts to Secure Funding
Quarterly Report
Medicale Corp. reports a reduced net loss for the three and six months ended March 31, 2025, while continuing efforts to raise capital and commence operations.
Summary
- Medicale Corp., incorporated in Nevada on August 17, 2020, has not yet commenced operations and is focused on preserving cash and raising capital.
- The company reported a net loss of $8,275 for the three months ended March 31, 2025, compared to a net loss of $11,564 for the same period in 2024.
- For the six months ended March 31, 2025, the net loss was $24,955, compared to $30,871 for the six months ended March 31, 2024.
- The company has an accumulated deficit of $200,800 and a working capital deficit of $25,932 as of March 31, 2025.
- As of May 12, 2025, there were 5,920,000 common shares issued and outstanding.
- The company's ability to continue as a going concern is dependent on securing additional investment capital.
- The company's principal place of business is located in Wellington, FL, provided on a rent-free basis by its sole officer and director.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to the company's lack of operations, accumulated deficit, and dependence on raising capital, although the reduced net loss is a minor positive.
Positives
- The net loss decreased for both the three and six months ended March 31, 2025, compared to the same periods in 2024.
- Cash flow used in operating activities decreased from $(58,788) to $(14,530) for the six months ended March 31, 2025 compared to the same period in 2024.
Negatives
- The company has not commenced operations and has not generated any revenue.
- The company has a significant accumulated deficit of $200,800 as of March 31, 2025.
- The company has a working capital deficit of $25,932 as of March 31, 2025.
- The company's cash balance is $0 as of March 31, 2025.
- The company is dependent on additional investment capital to fund operating expenses, raising concerns about its ability to continue as a going concern.
- The company's disclosure controls and procedures were not effective as of March 31, 2025.
Risks
- The company's ability to continue as a going concern is dependent on securing additional investment capital.
- The company has not yet commenced operations and has not generated any revenue.
- The company's disclosure controls and procedures were not effective as of March 31, 2025.
- There is substantial doubt about the company's ability to continue as a going concern.
- The company is subject to risks inherent in the establishment of a new business enterprise, including limited capital resources and possible changes in consumer interest.
Future Outlook
Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses and intends to position itself to raise additional funds through the capital markets.
Management Comments
- Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses.
- The Company intends to position itself so that it will be able to raise additional funds through the capital markets.
Industry Context
The company plans to operate in the dietary supplements and consulting services industries, which are competitive and subject to changing consumer preferences and regulatory conditions.
Comparison to Industry Standards
- Given that Medicale Corp. has not yet commenced operations, it is difficult to compare its performance to industry standards.
- Companies in the dietary supplement industry, such as Herbalife Nutrition and Nu Skin Enterprises, typically have established revenue streams and significant operating expenses related to manufacturing, marketing, and distribution.
- Consulting service companies, such as Accenture and McKinsey & Company, have revenue models based on billable hours and project fees, with significant expenses related to employee compensation and office space.
- Medicale Corp.'s current financial state, with no revenue and reliance on convertible notes for operating expenses, is not comparable to established companies in either industry.
Stakeholder Impact
- Shareholders face significant risk due to the company's financial condition and dependence on raising capital.
- Employees (if any) face uncertainty due to the company's lack of operations and financial instability.
- Creditors (holders of convertible notes) face risk of non-payment if the company is unable to raise additional capital or generate revenue.
Next Steps
- The company intends to position itself so that it will be able to raise additional funds through the capital markets.
- The company plans to offer consulting services and distribution of dietary supplements.
Key Dates
| Date | Description |
|---|---|
| 2020-08-17 | Medicale Corp. was incorporated in the State of Nevada. |
| 2022-12-28 | Magenta Acres, Inc. acquired approximately 54% of the issued and outstanding shares of Common Stock of the Company. |
| 2022-12-28 | Chen Zu De was appointed as Chief Executive Officer, Chairman of the Board, Treasurer and Secretary, and Director of the Company. |
| 2023-12-31 | The Company entered into a Convertible Note agreement with a third party at $48,186. |
| 2024-01-14 | The Company's Form 10-K was filed with the Securities and Exchange Commission. |
| 2024-03-31 | The Company entered into a Convertible Note agreement with a third party at $10,602. |
| 2024-06-30 | The Company entered into a Convertible Note agreement with a third party at $9,288. |
| 2024-08-19 | The Form 10-K was filed with the Securities and Exchange Commission (SEC). |
| 2024-09-30 | The Company entered into a Convertible Note agreement with a third party at $15,509. |
| 2024-12-31 | The Company entered into a Convertible Note agreement with a third party at $10,000. |
| 2025-03-31 | The Company entered into a Convertible Note agreement with a third party at $4,371. |
| 2025-03-31 | End of the quarterly period. |
| 2025-05-12 | Date as of which 5,920,000 common shares were issued and outstanding. |
| 2025-05-15 | Date of report signature. |
Keywords
Medicale Corp, financial results, net loss, going concern, convertible notes, capital raising, dietary supplements, consulting services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.